| Product Code: ETC12838446 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Influenza B Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Influenza B Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Influenza B Market - Industry Life Cycle |
3.4 Ireland Influenza B Market - Porter's Five Forces |
3.5 Ireland Influenza B Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Ireland Influenza B Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Ireland Influenza B Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
3.8 Ireland Influenza B Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Influenza B Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of flu vaccination in Ireland |
4.2.2 Government initiatives promoting flu vaccination programs |
4.2.3 Growing elderly population in Ireland |
4.3 Market Restraints |
4.3.1 Seasonal nature of the influenza virus |
4.3.2 Limited availability of effective vaccines |
4.3.3 Potential side effects associated with influenza vaccines |
5 Ireland Influenza B Market Trends |
6 Ireland Influenza B Market, By Types |
6.1 Ireland Influenza B Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Influenza B Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Ireland Influenza B Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Baloxavir), 2021 - 2031F |
6.1.4 Ireland Influenza B Market Revenues & Volume, By Symptom Management (Pain Relievers, Antihistamines), 2021 - 2031F |
6.2 Ireland Influenza B Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Ireland Influenza B Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Ireland Influenza B Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 Ireland Influenza B Market Revenues & Volume, By Inhalation, 2021 - 2031F |
6.3 Ireland Influenza B Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Ireland Influenza B Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Ireland Influenza B Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Ireland Influenza B Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 Ireland Influenza B Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland Influenza B Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Ireland Influenza B Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Ireland Influenza B Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Ireland Influenza B Market Import-Export Trade Statistics |
7.1 Ireland Influenza B Market Export to Major Countries |
7.2 Ireland Influenza B Market Imports from Major Countries |
8 Ireland Influenza B Market Key Performance Indicators |
8.1 Percentage of population vaccinated against influenza B |
8.2 Number of reported cases of influenza B in Ireland |
8.3 Rate of hospitalizations due to influenza B complications |
9 Ireland Influenza B Market - Opportunity Assessment |
9.1 Ireland Influenza B Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Ireland Influenza B Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Ireland Influenza B Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
9.4 Ireland Influenza B Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Influenza B Market - Competitive Landscape |
10.1 Ireland Influenza B Market Revenue Share, By Companies, 2024 |
10.2 Ireland Influenza B Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here